↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

122 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   2% sodium chondroitin sulfate   Chondroitin sulfate, Sulfate ion, sodium chondroitin sulfate   D00080   -   -   1件:
226 
 2   5% lidocaine/5 mg/ml estradiol compound cream   Estradiol, Epinephrine   D00095, D00105, D00996, D01413, D01617, D01953, D02149, D04061, D04063, D04064, D04065   11件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, ESR1, ESR2   9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
226 
 3   Adalimumab   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   15件:
19,
37,
41,
46,
56,
84,
96,
97,
151,
160,
164,
222,
226,
269,
271 
 4   Agn 203818   -   -   -   -   1件:
226 
 5   Alkalinized lidocaine-heparin   Heparin, Epinephrine   D00095, D00996, D02149, D07510   10件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SERPINC1   8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
226 
 6   Amitriptyline   Amitriptyline   D00809, D07448   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
78,
226,
299 
 7   Aqx-1125   AQX-1125   -   -   -   1件:
226 
 8   Aqx-1125 100 mg   AQX-1125   -   -   -   1件:
226 
 9   Aqx-1125 200 mg   AQX-1125   -   -   -   1件:
226 
 10   Asp3652   -   -   -   -   1件:
226 
 11   Asp6294   -   -   -   -   1件:
226 
 12   Bladder instillation with heparin/ lidocaine   Heparin, Epinephrine   D00095, D00996, D02149, D07510   10件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SERPINC1   8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
226 
 13   Bladder instillation with triamcinolone acetonide   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
226 
 14   Bladder instillation without triamcinolone acetonide   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
226 
 15   Bladder instillations   -   -   -   -   1件:
226 
 16   Botox   Botulinum toxin type A   D00783   1件: SNAP25   1件: Synaptic vesicle cycle   4件:
6,
13,
149,
226 
 17   Botox 200u in normal saline   -   -   -   -   1件:
226 
 18   Botulinum toxin a   Botulinum toxin type A   D00783   1件: SNAP25   1件: Synaptic vesicle cycle   4件:
13,
51,
149,
226 
 19   Buckwheat   Buckwheat   -   -   -   1件:
226 
 20   Bupivacaine   Bupivacaine   D01450, D07552   1件: SCN1A   1件: Dopaminergic synapse   7件:
46,
53,
70,
96,
168,
226,
298 
 21   Capsaicin   Capsaicin   D00250   1件: TRPV1   1件: Neuroactive ligand-receptor interaction   6件:
2,
6,
19,
86,
113,
226 
 22   Certolizumab pegol   Certolizumab pegol   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   6件:
37,
46,
96,
97,
226,
271 
 23   Chondroitin sulfate   Chondroitin sulfate, Sulfate ion   D00080   -   -   2件:
96,
226 
 24   Ciclosporin   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   13件:
26,
46,
49,
50,
53,
55,
60,
61,
97,
222,
226,
228,
269 
 25   Ciklosporin   -   -   -   -   1件:
226 
 26   Cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   33件:
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 27   Dexmedetomidine   Dexmedetomidine   D00514, D01205   3件: ADRA2A, ADRA2B, ADRA2C   1件: Neuroactive ligand-receptor interaction   11件:
2,
4,
6,
21,
34,
70,
113,
212,
215,
226,
280 
 28   Dimethyl sulfoxide   Dimethyl sulfoxide   D01043   -   -   1件:
226 
 29   Dmso   Dimethyl sulfoxide   D01043   -   -   1件:
226 
 30   Dmso cocktail   Dimethyl sulfoxide   D01043   -   -   1件:
226 
 31   Erb-041   -   -   -   -   3件:
46,
96,
226 
 32   Estradiol   Estradiol   D00105, D01413, D01617, D01953, D04061, D04063, D04064, D04065   2件: ESR1, ESR2   2件: Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway   5件:
13,
46,
49,
226,
299 
 33   Fospropofol   Fospropofol   D04257   -   -   1件:
226 
 34   Fospropofol (lusedra®) 10   Fospropofol   D04257   -   -   1件:
226 
 35   Fospropofol (lusedra®) 12   Fospropofol   D04257   -   -   1件:
226 
 36   Fospropofol (lusedra®) 6.5   Fospropofol   D04257   -   -   1件:
226 
 37   Gefapixant   Gefapixant   D11349   1件: P2RX3   1件: Neuroactive ligand-receptor interaction   2件:
85,
226 
 38   Glycine   Glycine   D00011   -   -   4件:
35,
86,
226,
299 
 39   Gralise   Gabapentin   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   2件: GABAergic synapse, MAPK signaling pathway   2件:
97,
226 
 40   Heparin   Heparin   D07510   1件: SERPINC1   1件: Complement and coagulation cascades   11件:
60,
70,
79,
84,
107,
224,
226,
280,
299,
316,
317 
 41   Hyaluronic acid   Hyaluronic acid   D08043   -   -   5件:
46,
53,
70,
226,
231 
 42   Hyaluronic acid and chondroitin sulfate   Chondroitin sulfate, Hyaluronic acid, Sulfate ion   D00080, D08043   -   -   1件:
226 
 43   Hyaluronic acid/chondroitin sulfate   Chondroitin sulfate, Hyaluronic acid, Sulfate ion   D00080, D08043   -   -   1件:
226 
 44   Hydrogen   Hydrogen   -   -   -   5件:
5,
6,
17,
97,
226 
 45   Ic cocktail   -   -   -   -   1件:
226 
 46   Intravesical onabotulinumtoxina injection   Botulinum toxin type A   D00783   1件: SNAP25   1件: Synaptic vesicle cycle   1件:
226 
 47   Ipd® (japanese tradename)   -   -   -   -   1件:
226 
 48   Ketorolac   Ketorolac   D00813, D08104   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   2件:
70,
226 
 49   Ketorolac tromethamine   Ketorolac, Tromethamine   D00396, D00813, D08104   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   1件:
226 
 50   Krp-116d   -   -   -   -   1件:
226 
 51   Lidocaine   Epinephrine   D00095, D00996, D02149   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   7件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   8件:
6,
13,
46,
86,
168,
226,
231,
256 
 52   Lidocaine releasing intravesical system - liris®   Epinephrine   D00095, D00996, D02149   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   7件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
226 
 53   Liposome encapsulated bont-a   -   -   -   -   1件:
226 
 54   Liposomes   -   -   -   -   1件:
226 
 55   Liris 400 mg   -   -   -   -   1件:
226 
 56   Liris low dose and liris high dose   -   -   -   -   1件:
226 
 57   Liris®   -   -   -   -   1件:
226 
 58   Liris® 400 mg   -   -   -   -   1件:
226 
 59   Lp-08 20mg   -   -   -   -   1件:
226 
 60   Lp-08 80mg   -   -   -   -   1件:
226 
 61   Metoprolol   Metoprolol   D00601, D02358, D05011   1件: ADRB1   2件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction   6件:
17,
57,
58,
113,
193,
226 
 62   Metoprolol tartrate oral tablet   Metoprolol   D00601, D02358, D05011   1件: ADRB1   2件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction   1件:
226 
 63   Mirabegron   Mirabegron   D09535   1件: ADRB3   2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction   3件:
6,
13,
226 
 64   Mn-001   -   -   -   -   1件:
226 
 65   Mn-001 bid   -   -   -   -   1件:
226 
 66   Mycofenolate mofetil (mmf)   -   -   -   -   1件:
226 
 67   Mycophenolate   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   33件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 68   Mycophenolate mofetil   Mycophenolic acid, Mycophenolate mofetil, mycophenolate mofetil   D00752, D05094, D05095, D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 69   Naloxone   Naloxone   D01340, D08249   3件: OPRD1, OPRK1, OPRM1   2件: Morphine addiction, Neuroactive ligand-receptor interaction   2件:
6,
226 
 70   Naloxone hydrochloride   Naloxone   D01340, D08249   3件: OPRD1, OPRK1, OPRM1   2件: Morphine addiction, Neuroactive ligand-receptor interaction   1件:
226 
 71   Normal saline   -   -   -   -   14件:
6,
17,
22,
36,
46,
49,
60,
94,
96,
211,
226,
276,
296,
299 
 72   Normal saline instillation   -   -   -   -   1件:
226 
 73   Nortriptyline   Nortriptyline   D00816, D08288   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   2件:
6,
226 
 74   Omalizumab   Omalizumab   D05251   1件: FCER1A   2件: Asthma, Fc epsilon RI signaling pathway   6件:
53,
65,
98,
162,
226,
299 
 75   Onabotulinumtoxin a   -   -   -   -   1件:
226 
 76   Onabotulinumtoxina   Botulinum toxin type A   D00783   1件: SNAP25   1件: Synaptic vesicle cycle   3件:
6,
13,
226 
 77   Oxn 10/5 mg pr   -   -   -   -   1件:
226 
 78   Oxn 20/10 mg pr   -   -   -   -   1件:
226 
 79   Oxn 5/2.5 mg pr   -   -   -   -   1件:
226 
 80   Oxycodone   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   1件: Neuroactive ligand-receptor interaction   7件:
6,
13,
46,
70,
226,
231,
298 
 81   Oxycodone hydrochloride   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   1件: Neuroactive ligand-receptor interaction   3件:
70,
226,
298 
 82   Oxycodone naloxone prolonged release tablets   Naloxone, Oxycodone   D01340, D03783, D05312, D05462, D08249   3件: OPRD1, OPRK1, OPRM1   2件: Morphine addiction, Neuroactive ligand-receptor interaction   1件:
226 
 83   Oxycodone/naloxone prolonged release t   Naloxone, Oxycodone   D01340, D03783, D05312, D05462, D08249   3件: OPRD1, OPRK1, OPRM1   2件: Morphine addiction, Neuroactive ligand-receptor interaction   1件:
226 
 84   Oxycodone/naloxone prolonged release tablets 10/5 mg   Naloxone, Oxycodone   D01340, D03783, D05312, D05462, D08249   3件: OPRD1, OPRK1, OPRM1   2件: Morphine addiction, Neuroactive ligand-receptor interaction   1件:
226 
 85   Oxycodone/naloxone prolonged release tablets 20/10 mg   Naloxone, Oxycodone   D01340, D03783, D05312, D05462, D08249   3件: OPRD1, OPRK1, OPRM1   2件: Morphine addiction, Neuroactive ligand-receptor interaction   1件:
226 
 86   Oxycodone/naloxone prolonged release tablets 5/2.5 mg   Naloxone, Oxycodone   D01340, D03783, D05312, D05462, D08249   3件: OPRD1, OPRK1, OPRM1   2件: Morphine addiction, Neuroactive ligand-receptor interaction   1件:
226 
 87   Oxygen   Oxygen   D00003   -   -   14件:
46,
49,
70,
84,
85,
86,
88,
90,
96,
97,
193,
226,
299,
330 
 88   Oxytocin   Oxytocin   D00089   1件: OXTR   2件: Neuroactive ligand-receptor interaction, Oxytocin signaling pathway   4件:
127,
193,
206,
226 
 89   Pd 0299685   PD 0299685   -   -   -   1件:
226 
 90   Pd 0299685 at 15mg bid   PD 0299685   -   -   -   1件:
226 
 91   Pd 0299685 at 30mg bid   PD 0299685   -   -   -   1件:
226 
 92   Pentosan polysulfate   Pentosan Polysulfate   D05428   -   -   3件:
19,
26,
226 
 93   Pentosan polysulfate sodium 100 mg   Pentosan Polysulfate, pentosan polysulfate sodium   D05428   -   -   1件:
226 
 94   Pf-04383119   -   -   -   -   1件:
226 
 95   Placebo   -   -   -   -   20件:
3,
6,
13,
14,
40,
46,
49,
50,
51,
66,
67,
79,
85,
86,
88,
96,
97,
144,
149,
226 
 96   Platelet enriched plasma   -   -   -   -   1件:
226 
 97   Platelet-rich plasma   -   -   -   -   1件:
226 
 98   Prograf   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   3件:
60,
222,
226 
 99   Propiverine   Propiverine   D08441   9件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   3件: Calcium signaling pathway, Cholinergic synapse, Neuroactive ligand-receptor interaction   1件:
226 
 100   Propiverine hydrochloride   Propiverine   D08441   9件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   3件: Calcium signaling pathway, Cholinergic synapse, Neuroactive ligand-receptor interaction   1件:
226 
 101   Rimso   rimso   D01043   -   -   1件:
226 
 102   Rimso 50   Dimethyl sulfoxide, rimso, rimso 50   D01043   -   -   1件:
226 
 103   Rn624, ri624   -   -   -   -   1件:
226 
 104   Sandimmun   sandimmun   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   4件:
53,
60,
113,
226 
 105   Sandimmun neoral   Ciclosporin, sandimmun, sandimmun neoral   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   2件:
60,
226 
 106   Sildenafil   Sildenafil   D02229, D08514   1件: PDE5A   1件: cGMP-PKG signaling pathway   15件:
6,
46,
50,
51,
85,
86,
113,
210,
211,
212,
225,
226,
278,
294,
299 
 107   Sugar pill   -   -   -   -   7件:
6,
49,
67,
70,
86,
206,
226 
 108   Sulfate   Sulfate ion   -   -   -   22件:
2,
6,
11,
13,
26,
34,
36,
46,
49,
60,
61,
64,
66,
79,
86,
96,
222,
226,
265,
296,
297,
299 
 109   Suplatast tosilate   -   -   -   -   1件:
226 
 110   Tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   29件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 111   Tanezumab   Tanezumab   D09387   -   -   2件:
226,
298 
 112   Targinact 10 mg/5 mg prolonged-release tablets   -   -   -   -   1件:
226 
 113   Targinact 20mg/10 mg prolonged-release tablets   -   -   -   -   1件:
226 
 114   Targinact 5mg/2.5 mg prolonged-release tablets   -   -   -   -   1件:
226 
 115   Tramadol   Tramadol   D01355, D08623   1件: OPRM1   1件: Neuroactive ligand-receptor interaction   5件:
46,
70,
78,
226,
271 
 116   Triamcinolone   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   8件:
35,
46,
56,
70,
90,
96,
226,
298 
 117   Tromethamine   Tromethamine   D00396   -   -   1件:
226 
 118   Tti-1612   -   -   -   -   1件:
226 
 119   Urg101   -   -   -   -   1件:
226 
 120   Water   Water   D00001   -   -   18件:
2,
5,
6,
13,
17,
19,
35,
46,
53,
57,
63,
65,
67,
84,
97,
226,
278,
299 
 121   Ym672   -   -   -   -   1件:
226 
 122   Ym672 (ipd®)   -   -   -   -   1件:
226 

先頭へ